EGFR and squamous cell carcinoma: The near ubiquitous overexpression of epidermal growth factor receptor (EGFR)—with estimates of > 90 % overexpression in squamous cell carcinoma (SCC) [2, 3]—has led to the development of numerous molecular therapeutic agents, which have been subsequently leveraged for fluorescence imaging [4–8].